Deferred Consent in Pediatric Drug Trials: Moving from Why to How Martin OffringaTerry P. Klassen Commentary 28 October 2021 Pages: 533 - 535
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance Giuseppe BaroneAilish BarryMax M. van Noesel Therapy in Practice Open access 20 September 2021 Pages: 537 - 548
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia Susanna EspositoTimothy J. CarrothersMichal Kantecki Review Article Open access 31 August 2021 Pages: 549 - 563
Deferred Consent in Neonatal Clinical Research: Why, When, How? Dilini I. ImbulanaLouise S. OwenBrett J. Manley Review Article 15 October 2021 Pages: 565 - 573
Use of Furosemide and Chlorothiazide Combination Continuous Infusion in Furosemide-Refractory Patients in the Pediatric Intensive Care Unit: A Retrospective Cohort Study Summer R. RecordAaron A. HarthanSandeep Tripathi Original Research Article 11 October 2021 Pages: 575 - 582
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical Trials Stephen V. FaraoneRoberto GomeniAzmi Nasser Original Research Article Open access 15 September 2021 Pages: 583 - 589
Randomized Clinical Trial of Metoclopramide as Prophylaxis of Gastroesophageal Reflux Disease in Preterm Infants Adriana del Pilar Montealegre-PomarNathalie Charpak Original Research Article 25 October 2021 Pages: 591 - 599
Secukinumab: A Review in Moderate to Severe Pediatric Plaque Psoriasis Hannah A. Blair Adis Drug Evaluation Open access 19 October 2021 Pages: 601 - 608
Teriflunomide: Pediatric First Approval Julia Paik AdisInsight Report 01 October 2021 Pages: 609 - 613
Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia Susanna EspositoTimothy J. CarrothersMichal Kantecki Correction Open access 07 October 2021 Pages: 615 - 615